Igor Makhlin

9PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 13, 2026
Mutability Dependence of Breast Cancer Metastasis and Latency to Recurrence.

|Sep 02, 2025
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial.

Angela DeMichele, Amy S Clark, Emily Shea

|Apr 04, 2024
Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial.

Igor Makhlin, Biniyam G Demissei, Ralph D'Agostino

|Jun 10, 2023
Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer.

Michael G Fradley, Nam H K Nguyen, David Madnick

|Nov 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.

Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto

|Oct 21, 2022
18F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor-Positive Bone-Dominant Metastatic Breast Cancer.

Igor Makhlin, Katrina Esther Korhonen, Melissa Lynne Martin

Pageof 2

Frequent Collaborators

6 joint publications

Angela M DeMichele

3 joint publications

Amy S Clark

2 joint publications

Lewis A Chodosh

2 joint publications

Bonnie Ky